Pacific Biosciences Of California, Inc. financial data

Symbol
PACB on Nasdaq
Industry
Laboratory Analytical Instruments
Location
1305 O'brien Drive, Menlo Park, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
NANOFLUIDICS INC (to 7/28/2004)
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 681 % +63.1%
Quick Ratio 60.6 % +139%
Debt-to-equity 162 % -15.1%
Return On Equity -61.4 % -21.4%
Return On Assets -23.5 % -34.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 273M shares +8.77%
Common Stock, Shares, Outstanding 272M shares +8.79%
Entity Public Float 3.32B USD +235%
Common Stock, Value, Issued 272K USD +8.8%
Weighted Average Number of Shares Outstanding, Basic 272M shares +8.92%
Weighted Average Number of Shares Outstanding, Diluted 272M shares +8.92%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 36M USD -24.3%
Cost of Revenue 144M USD +41.2%
Research and Development Expense 174M USD -5.86%
Operating Income (Loss) -427M USD -31%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -412M USD -29%
Income Tax Expense (Benefit) -11.4M USD
Net Income (Loss) Attributable to Parent -400M USD -25.4%
Earnings Per Share, Basic -1.5 USD/shares -11.1%
Earnings Per Share, Diluted -1.5 USD/shares -11.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 99.5M USD -52.4%
Accounts Receivable, after Allowance for Credit Loss, Current 32.4M USD +34.9%
Inventory, Net 68.6M USD +1.46%
Assets, Current 628M USD -32.9%
Property, Plant and Equipment, Net 34.9M USD -13.4%
Operating Lease, Right-of-Use Asset 22.4M USD -38.6%
Intangible Assets, Net (Excluding Goodwill) 443M USD +8.18%
Goodwill 369M USD -9.98%
Other Assets, Noncurrent 9.79M USD -25.5%
Assets 1.51B USD -18.3%
Accounts Payable, Current 17.5M USD +5.91%
Employee-related Liabilities, Current 29.3M USD +68.3%
Accrued Liabilities, Current 22.5M USD -16.9%
Contract with Customer, Liability, Current 19.2M USD -23.1%
Liabilities, Current 78.4M USD -71.1%
Contract with Customer, Liability, Noncurrent 5.71M USD +14.3%
Operating Lease, Liability, Noncurrent 19.6M USD -46.4%
Other Liabilities, Noncurrent 751K USD -10.3%
Liabilities 1.02B USD -15.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -523K USD +80.5%
Retained Earnings (Accumulated Deficit) -2.09B USD -23.7%
Stockholders' Equity Attributable to Parent 493M USD -23.3%
Liabilities and Equity 1.51B USD -18.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -75.7M USD +20.1%
Net Cash Provided by (Used in) Financing Activities 6.55M USD -96.7%
Net Cash Provided by (Used in) Investing Activities -34.1M USD +53%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 272M shares +8.79%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -103M USD -459%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 102M USD -52%
Deferred Tax Assets, Valuation Allowance 526M USD +18%
Deferred Tax Assets, Gross 642M USD +16%
Operating Lease, Liability 41.2M USD -17.5%
Depreciation 3.24M USD +17.6%
Payments to Acquire Property, Plant, and Equipment 3.88M USD +4.25%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -398M USD -25.8%
Lessee, Operating Lease, Liability, to be Paid 46.7M USD -20.2%
Property, Plant and Equipment, Gross 111M USD +4.37%
Operating Lease, Liability, Current 12.5M USD +35.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.3M USD +2.41%
Lessee, Operating Lease, Liability, to be Paid, Year One 12.1M USD +1.06%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.53M USD -35.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 12.4M USD +1.08%
Deferred Tax Assets, Operating Loss Carryforwards 435M USD +8.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 14.6M USD +39.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.93M USD -19.9%
Operating Lease, Payments 1.88M USD +76.7%
Additional Paid in Capital 2.58B USD +10.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 6.85M USD +2829%
Deferred Tax Assets, Net of Valuation Allowance 117M USD +7.61%
Share-based Payment Arrangement, Expense 73M USD +0.39%
Interest Expense 14.3M USD -2.29%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%